Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26FM3E9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,925
Award facts
- Contract value 100% obligated
- $20,925.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,925.46 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose injections on November 10, 2025, with completion targeted for November 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, maintains an extensive portfolio of delivery orders through the DLA Medical Supply Chain to support military and veteran healthcare systems. This contract for Cosentyx, a prescription immunosuppressant used to treat conditions such as psoriasis and rheumatoid arthritis, exemplifies the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to support Department of Defense healthcare operations globally. The delivery order structure allows the government to procure specific quantities of pharmaceutical products as needed under the umbrella of the larger IDC vehicle, enabling flexible and efficient medical supply chain management.
Quick answers
Who was awarded contract SPE2DR26FM3E9?
SPE2DR26FM3E9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FM3E9 worth?
The government has obligated $20,925 on SPE2DR26FM3E9.
Is contract SPE2DR26FM3E9 an order under another contract?
Yes. SPE2DR26FM3E9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM3E9 competed?
The extent of competition for SPE2DR26FM3E9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award